274 related articles for article (PubMed ID: 16724578)
1. Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation.
Yang SG; Kim DD; Chung SJ; Shim CK
Int J Clin Pharmacol Ther; 2006 May; 44(5):233-9. PubMed ID: 16724578
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R
Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin A soft gelatin capsule formulations.
Avramoff A; Laor A; Kitzes-Cohen R; Farin D; Domb AJ
Int J Clin Pharmacol Ther; 2007 Feb; 45(2):126-32. PubMed ID: 17323793
[TBL] [Abstract][Full Text] [Related]
4. Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of Neoimmun.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Faerber L; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):393-9. PubMed ID: 17571254
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and patient acceptance of cyclosporine soft gelatin capsules in renal allograft recipients.
Min DI; Hwang GC; Bergstrom S; Madras PN; Shaffer D; Sahyoun AI; Monaco AP
Ann Pharmacother; 1992 Feb; 26(2):175-9. PubMed ID: 1554925
[TBL] [Abstract][Full Text] [Related]
6. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.
Hirunpanich V; Sato H
Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine bioequivalence study: quantification using fluorescence polarization immunoassay (FPIA) and radioimmunoassay (RIA).
Mendes GD; de Oliveira CH; Sucupira M; Donato JL; Moreno RA; De Nucci G
Int J Clin Pharmacol Ther; 2004 Feb; 42(2):125-32. PubMed ID: 15180174
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis.
Fu LW; Yang LY; Chen WP; Lin CY
Br J Clin Pharmacol; 1997 Aug; 44(2):125-7. PubMed ID: 9278195
[TBL] [Abstract][Full Text] [Related]
9. Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral.
Kees F; Mair G; Dittmar M; Bucher M
Transplant Proc; 2004 Dec; 36(10):3234-8. PubMed ID: 15686736
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet.
Garikipati V; Toops DS; Fang Q
Curr Med Res Opin; 2008 Jul; 24(7):1869-76. PubMed ID: 18593524
[TBL] [Abstract][Full Text] [Related]
11. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation.
Mueller EA; Kovarik JM; van Bree JB; Tetzloff W; Grevel J; Kutz K
Pharm Res; 1994 Feb; 11(2):301-4. PubMed ID: 8165192
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulation.
Kovarik JM; Mueller EA; Johnston A; Hitzenberger G; Kutz K
Pharmacotherapy; 1993; 13(6):613-7. PubMed ID: 8302687
[TBL] [Abstract][Full Text] [Related]
13. Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women.
Teo SK; Scheffler MR; Kook KA; Tracewell WG; Colburn WA; Stirling DI; Thomas SD
Biopharm Drug Dispos; 2000 Jan; 21(1):33-40. PubMed ID: 11038436
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
[TBL] [Abstract][Full Text] [Related]
15. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
16. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence of Neoplanta capsule to Sandimmune Neoral, microemulsion formulations of cyclosporin A in human subjects.
Lee YJ; Chung SJ; Shim CK
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):210-5. PubMed ID: 9587047
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
Schädeli F; Marti HP; Frey FJ; Uehlinger DE
Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability of levodropropizine 60 mg capsule and syrup formulations in healthy male Korean volunteers: a singledose, randomized-sequence, open-label, two-way crossover study.
Jang JW; Seo JH; Jo MH; Lee YJ; Cho YW; Yim SV; Lee KT
Int J Clin Pharmacol Ther; 2013 Feb; 51(2):152-60. PubMed ID: 23351597
[TBL] [Abstract][Full Text] [Related]
20. [Bioequivalence research of cyclosporin soft capsules].
Wu Y; Mao M; Wang L; Jiang X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):311-4, 331. PubMed ID: 22616181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
